Details of the Drug Formulaction

General Information of Drug Formulation (ID: F19003)

• Formulation Name: Riluzole 50 mg tablet
• Company: Ascend Laboratories; Kaiser Foundation Hospitals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Riluzole	(DMECBWN)	Amyotrophic lateral sclerosis	8B60.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Brushite	(E00392)	104805	Diluent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent